{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:45:04Z","timestamp":1761561904075},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":358,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Rheum Dis"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1111\/1756-185x.12467","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T05:07:34Z","timestamp":1410152854000},"page":"40-45","source":"Crossref","is-referenced-by-count":13,"title":["The long-term effects of anti-TNF-\u03b1 agents on patients with chronic viral hepatitis C and B infections"],"prefix":"10.1111","volume":"18","author":[{"given":"Tuncer","family":"Temel","sequence":"first","affiliation":[{"name":"Division of Gastroenterology; Faculty of Medicine; Department of Internal Medicine; Eski\u015fehir Osmangazi University; Eskisehir Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00f6nd\u00fc \u00dcsk\u00fcdar","family":"Cansu","sequence":"additional","affiliation":[{"name":"Division of Rheumotology; Faculty of Medicine; Department of Internal Medicine; Eski\u015fehir Osmangazi University; Eskisehir Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cengiz","family":"Korkmaz","sequence":"additional","affiliation":[{"name":"Division of Rheumotology; Faculty of Medicine; Department of Internal Medicine; Eski\u015fehir Osmangazi University; Eskisehir Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timu\u00e7in","family":"Ka\u015fifo\u011flu","sequence":"additional","affiliation":[{"name":"Division of Rheumotology; Faculty of Medicine; Department of Internal Medicine; Eski\u015fehir Osmangazi University; Eskisehir Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015feg\u00fcl","family":"\u00d6zakyol","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology; Faculty of Medicine; Department of Internal Medicine; Eski\u015fehir Osmangazi University; Eskisehir Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,8]]},"reference":[{"key":"10.1111\/1756-185X.12467-BIB0001|apl12467-cit-0001","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-8278(99)80060-9","article-title":"Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity","volume":"30","author":"Zylberberg","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/1756-185X.12467-BIB0002|apl12467-cit-0002","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1023\/A:1018804426724","article-title":"Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection","volume":"42","author":"Nelson","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1111\/1756-185X.12467-BIB0003|apl12467-cit-0003","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1365-2249.1999.00812.x","article-title":"HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines","volume":"115","author":"Schlaak","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/1756-185X.12467-BIB0004|apl12467-cit-0004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1373.2000.22335.x","article-title":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis","volume":"223","author":"Herbein","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/1756-185X.12467-BIB0005|apl12467-cit-0005","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3899\/jrheum.081246","article-title":"Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature","volume":"36","author":"Zingarelli","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/1756-185X.12467-BIB0006|apl12467-cit-0006","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jbspin.2008.11.005","article-title":"Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy","volume":"76","author":"Wendling","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1111\/1756-185X.12467-BIB0007|apl12467-cit-0007","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3899\/jrheum.081324","article-title":"Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy","volume":"36","author":"Chung","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/1756-185X.12467-BIB0008|apl12467-cit-0008","first-page":"421","article-title":"Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis","volume":"35","author":"Cansu","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/1756-185X.12467-BIB0009|apl12467-cit-0009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10067-013-2378-0","article-title":"Long-term safety of anti-TNF-\u03b1 in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients","volume":"33","author":"Costa","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1111\/1756-185X.12467-BIB0010|apl12467-cit-0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2004.11.025","article-title":"Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study","volume":"42","author":"Zein","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/1756-185X.12467-BIB0011|apl12467-cit-0011","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.62.11.1078","article-title":"Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection","volume":"62","author":"Peterson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1756-185X.12467-BIB0012|apl12467-cit-0012","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.20702","article-title":"Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection","volume":"51","author":"Parke","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1756-185X.12467-BIB0013|apl12467-cit-0013","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/kel123","article-title":"Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis","volume":"45","author":"Roux","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/1756-185X.12467-BIB0014|apl12467-cit-0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-8278(98)80198-0","article-title":"Characteristics of patients with dual infection by hepatitis B and C viruses","volume":"28","author":"Zarski","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/1756-185X.12467-BIB0015|apl12467-cit-0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.22794","article-title":"HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV","volume":"49","author":"Sagnelli","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/1756-185X.12467-BIB0016|apl12467-cit-0016","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.22951","article-title":"Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference","volume":"50","author":"Bellecave","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/1756-185X.12467-BIB0017|apl12467-cit-0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14712598.2012.646986","article-title":"Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management","volume":"12","author":"Vigan\u00f2","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/1756-185X.12467-BIB0018|apl12467-cit-0018","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60","author":"European Association for the Study of the Liver","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/1756-185X.12467-BIB0019|apl12467-cit-0019","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"AASLD diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"American Association for the Study of Liver Disease","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/1756-185X.12467-BIB0020|apl12467-cit-0020","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s10067-006-0392-1","article-title":"Long-term anti-TNF alpha therapy for ankylosing spondylitis in two patients with chronic HBV infection","volume":"26","author":"Sakellariou","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1111\/1756-185X.12467-BIB0021|apl12467-cit-0021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL Clinical Practice Guidelines: management of chronichepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J Hepatol"},{"issue":"3","key":"10.1111\/1756-185X.12467-BIB0022|apl12467-cit-0022","first-page":"1","article-title":"AASLD clinical practice guidelines: chronic hepatitis B","volume":"50","author":"American Association for the Study of Liver Disease","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/1756-185X.12467-BIB0023|apl12467-cit-0023","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/ard.2009.127233","article-title":"Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection","volume":"69","author":"Vassilopoulos","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1111\/1756-185X.12467-BIB0024|apl12467-cit-0024","first-page":"118","article-title":"Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy","volume":"31","author":"Lee","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/1756-185X.12467-BIB0025|apl12467-cit-0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3899\/jrheum.090436","article-title":"Possible reactivation of potential hepatitis B virus occult infection by tumor necrosis factor-\u03b1 blocker in the treatment of rheumatic diseases","volume":"37","author":"Kim","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1111\/1756-185X.12467-BIB0026|apl12467-cit-0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/1756-185X.12184","article-title":"Infliximab and occult Hepatitis B infection: to treat or not to treat?","volume":"16","author":"Goel","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1111\/1756-185X.12467-BIB0027|apl12467-cit-0027","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/1756-185X.12125","article-title":"Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus","volume":"16","author":"Zhang","year":"2013","journal-title":"Int J Rheum Dis"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.12467","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/1756-185X.12467\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:30:30Z","timestamp":1625495430000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.12467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1111\/1756-185x.12467","relation":{},"ISSN":["1756-1841"],"issn-type":[{"value":"1756-1841","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,8]]}}}